Cargando…
Combined Treatments of Magnetic Intra-Lysosomal Hyperthermia with Doxorubicin Promotes Synergistic Anti-Tumoral Activity
Doxorubicin is a cytotoxic drug used for the treatment of many cancer types. However, its significant dose-related adverse effects including cardiotoxicity may hamper its efficiency. Moreover, the multidrug resistance that appears during treatments limits anti-cancer therapies. Hyperthermia has been...
Autores principales: | El Hajj Diab, Darine, Clerc, Pascal, Serhan, Nizar, Fourmy, Daniel, Gigoux, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071107/ https://www.ncbi.nlm.nih.gov/pubmed/29954075 http://dx.doi.org/10.3390/nano8070468 |
Ejemplares similares
-
Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fields
por: Lopez, Sara, et al.
Publicado: (2021) -
Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER
por: Gigoux, Véronique, et al.
Publicado: (2013) -
Hyperthermia-Triggered Doxorubicin Release from Polymer-Coated Magnetic Nanorods
por: Reyes-Ortega, Felisa, et al.
Publicado: (2019) -
Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia
por: Sharma, Anirudh, et al.
Publicado: (2019) -
A Smart Hyperthermia Nanofiber-Platform-Enabled Sustained Release of Doxorubicin and 17AAG for Synergistic Cancer Therapy
por: Chen, Lili, et al.
Publicado: (2021)